19992019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Rosanna Cardani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies

Renna, L. V., Bosè, F., Brigonzi, E., Fossati, B., Meola, G. & Cardani, R., Mar 2019, In : PLoS One. 14, 3, e0214254.

Research output: Contribution to journalArticle

Open Access
  • Dysregulation of circular RNAs in myotonic dystrophy type 1

    Voellenkle, C., Perfetti, A., Carrara, M., Fuschi, P., Renna, L. V., Longo, M., Sain, S. B., Cardani, R., Valaperta, R., Silvestri, G., Legnini, I., Bozzoni, I., Furling, D., Gaetano, C., Falcone, G., Meola, G. & Martelli, F., Apr 2 2019, In : International Journal of Molecular Sciences. 20, 8, 1938.

    Research output: Contribution to journalArticle

    Open Access
  • TNNT2 missplicing in skeletal muscle as a cardiac biomarker in myotonic dystrophy type 1 but not in myotonic dystrophy type 2

    Bosè, F., Renna, L. V., Fossati, B., Arpa, G., Labate, V., Milani, V., Botta, A., Micaglio, E., Meola, G. & Cardani, R., Sep 1 2019, In : Frontiers in Neurology. 10, SEP, 992.

    Research output: Contribution to journalArticle

    Open Access
  • Flecainide-induced Brugada syndrome in a patient with skeletal muscle sodium channelopathy: A case report with critical therapeutical implications and review of the literature

    Cavalli, M., Fossati, B., Vitale, R., Brigonzi, E., Ricigliano, V. A. G., Saraceno, L., Cardani, R., Pappone, C. & Meola, G., May 30 2018, In : Frontiers in Neurology. 9, MAY, 385.

    Research output: Contribution to journalArticle

  • High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2

    Cappella, M., Perfetti, A., Cardinali, B., Garcia-Manteiga, J. M., Carrara, M., Provenzano, C., Fuschi, P., Cardani, R., Renna, L. V., Meola, G., Falcone, G. & Martelli, F., Jul 1 2018, In : Cell Death and Disease. 9, 7, 729.

    Research output: Contribution to journalArticle